Latest Statin Stories

EL CAJON, Calif., Feb. 9, 2011 /PRNewswire/ -- On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis--muscle breakdown--are so rare that it suggests an additional causal factor, such as a drug. Drugs known as 'statins,' widely used to lower cholesterol, are known in rare cases to cause rhabdomyolysis. It seems more likely, however, that amphetamines, prescribed...

DUBLIN and MYSTIC, Conn., Feb. 2, 2011 /PRNewswire/ -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Paul E. Huff has joined the Company as Chief Commercial Officer. In this role, Mr. Huff is responsible for driving Amarin's AMR101 commercialization strategy, including all marketing and sales planning and implementation, including product launch activities. He will also provide business...

Healthy people may derive no benefit from taking cholesterol-lowering statins, according to a review of previous studies. The report, published in The Cochrane Library concluded that statins reduced death rates in high-risk patients but said there was no evidence to justify their use in people at low risk of developing heart disease.The National Institute for Health and Clinical Excellence recommends statins for people who have a 20 percent or greater chance of developing cardiovascular...

Heart rhythm abnormality linked to increased risk of deathAmong older adults with a recent heart attack (myocardial infarction), those with lower levels of kidney function are less likely to take their medications as prescribed, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN)."Several types of medications have proven benefit for preventing recurrent heart attacks, yet only about half of people with heart disease...

Elevated fat and cholesterol levels found in a typical American-style diet play an important role in the growth and spread of breast cancer, say researchers at the Kimmel Cancer Center at Jefferson.The study, published in the January issue of The American Journal of Pathology, examines the role of fat and cholesterol in breast cancer development using a mouse model. The results show that mice fed a Western diet and predisposed to develop mammary tumors, can develop larger tumors that are...

Patent filing is based on synergistic findings suggesting enhanced plaque management with RVX-208 in combination with statins TSX Exchange Symbol: RVX CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce today that it has filed additional new patent protection based on novel findings derived from its recently completed ASSERT Phase 2 clinical trial. A new patent application has been filed for novel dosing...

MYSTIC, Conn. and DUBLIN, Nov. 29, 2010 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101. The MARINE study, investigating AMR101 as a treatment for very high triglycerides (>=500 mg/dL), met its primary efficacy endpoints as defined in the...

Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis. A new explanation for these findings has been discovered by researchers at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy & Pharmaceutical Sciences, who describe for the first time how statins activate the...

A second AHA presentation includes mouse model data showing plaque reduction. TSX Exchange Symbol: RVX CHICAGO, Nov. 17 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX)  announces its top line results of the ASSERT Phase 2 clinical trial which will be highlighted at the prestigious American Heart Association Scientific Sessions 2010 Late Breaking Clinical Trial session, by principal investigator Dr. Stephen Nicholls of the Cleveland Clinic. The top line...

(Ivanhoe Newswire) "“ Patients with coronary artery disease (CAD) presenting with acute heart attacks, or ST-elevated myocardial infarction (STEMI), obviously showing many risk factors, are rarely on primary preventive medications."For those patients with known CAD, 100 percent should be taking aspirin and 90 percent on a statin, but we found only 70 percent were taking aspirin and only 61 percent were taking a statin," study investigator Kevin J. Graham, MD, president of the...